GAMMA Investing’s XBiotech XBIT Stock Holding History

GAMMA Investing’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-151	Closed	-$596	–	3888
2024 Q4	$596	Buy	+151	New	+$1.03K	﹤0.01%	3540

Other funds holding XBIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GAMMA Investing's XBIT Position: Q1 2025 in Review

GAMMA Investing sold out of XBiotech (XBIT) in Q1 2025, closing a stake of 151 shares — an estimated $596 sold.

GAMMA Investing first reported a position in XBIT in Q4 2024 and held it in 1 quarter. The position peaked at $596 in Q4 2024. 55 funds tracked by Wall St. Rank hold XBIT as of Q1 2025.

GAMMA Investing reported no remaining XBiotech position as of Q1 2025 after selling out during the quarter.
GAMMA Investing sold 151 XBiotech shares in Q1 2025, an estimated $596.
GAMMA Investing first reported a position in XBiotech in Q4 2024 and held it in 1 quarter.
GAMMA Investing's XBiotech position peaked at $596 in Q4 2024.
55 funds tracked by Wall St. Rank held XBiotech as of Q1 2025.

Based on GAMMA Investing's 13F filing for Q1 2025, filed 7 Apr 2025.